Alisen Ayitewala

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Escherichia Coli

Men Who Have Sex With Men

Top Venues

Access microbiology

AIDS research and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen Kanyerezi, Ivan Sserwadda, Aloysious Ssemaganda, Julius Seruyange, Alisen Ayitewala, Hellen Rosette Oundo, Wilson Tenywa, Brian A Kagurusi, Godwin Tusabe, Stacy Were, Isaac Ssewanyana, Susan Nabadda, Maria Magdalene Namaganda, Gerald Mboowa
HIV-DRIVES: HIV drug resistance identification, variant evaluation, and surveillance pipeline. Access microbiology 6 (7) (2024)
Stephen Kanyerezi, Ivan Sserwadda, Aloysious Ssemaganda, Julius Seruyange, Alisen Ayitewala, Hellen Rosette Oundo, Wilson Tenywa, Brian A Kagurusi, Godwin Tusabe, Stacy Were, Isaac Ssewanyana, Susan Nabadda, Maria Magdalene Namaganda, Gerald Mboowa
HIV-DRIVES: HIV drug resistance identification, variant evaluation, and surveillance pipeline. Access microbiology 6 (7) (2024)
Stephen Kanyerezi, Ivan Sserwadda, Aloysious Ssemaganda, Julius Seruyange, Alisen Ayitewala, Hellen Rosette Oundo, Wilson Tenywa, Brian A Kagurusi, Godwin Tusabe, Stacy Were, Isaac Ssewanyana, Susan Nabadda, Maria Magdalene Namaganda, Gerald Mboowa
HIV-DRIVES: HIV drug resistance identification, variant evaluation, and surveillance pipeline. Access microbiology 6 (7) (2024)
Alisen Ayitewala, Isaac Ssewanyana, Charles Kiyaga
Next generation sequencing based in-house HIV genotyping method: validation report. AIDS research and therapy 18 (1) (2021)
Alisen Ayitewala, Fred Kyeyune, Pamela Ainembabazi, Eva Nabulime, Charles Drago Kato, Immaculate Nankya
Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda. AIDS research and therapy 17 (1) (2020)